Several factors discourage the implementation of cancer screening to the population in
general, which would result in earlier diagnosis and an expected improved survival.
Concurrent in vivo and in vitro research has shown that drug acetylation activity is
increased in cancer. Amantadine may be of value in detecting the presence of cancer.
Accordingly, this study will examine how Amantadine is eliminated by the body in cancer
patients. This is an important step in validating a cancer detection method that can be
implemented economically for screening of large numbers of people.
Details
Lead Sponsor:
University of Manitoba
Collaborators:
BioMark Technologies Inc. St. Boniface General Hospital Research Centre St. Boniface Hospital